Danapha Pharmaceutical JSC (HSTC:DAN) EBIT per Share : ₫ (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Danapha Pharmaceutical JSC EBIT per Share?

Danapha Pharmaceutical JSC's EBIT per Share for the six months ended in . 20 was ₫0.00. Danapha Pharmaceutical JSC does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Danapha Pharmaceutical JSC's EBIT per Share or its related term are showing as below:

HSTC:DAN's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 6.8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Danapha Pharmaceutical JSC's EBIT for the six months ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC EBIT per Share Historical Data

The historical data trend for Danapha Pharmaceutical JSC's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danapha Pharmaceutical JSC EBIT per Share Chart

Danapha Pharmaceutical JSC Annual Data

Trend

EBIT per Share

Danapha Pharmaceutical JSC Semi-Annual Data

EBIT per Share

Danapha Pharmaceutical JSC EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Danapha Pharmaceutical JSC's EBIT per Share for the fiscal year that ended in . 20 is calculated as

	EBIT per Share		(A: . 20 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=		/	0
=	N/A

Danapha Pharmaceutical JSC's EBIT per Share for the quarter that ended in . 20 is calculated as

	EBIT per Share		(Q: . 20 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=		/	0
=	N/A

Danapha Pharmaceutical JSC (HSTC:DAN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Danapha Pharmaceutical JSC EBIT per Share Related Terms

Thank you for viewing the detailed overview of Danapha Pharmaceutical JSC's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Danapha Pharmaceutical JSC Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Danapha Pharmaceutical JSC (HSTC:DAN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Dung Si Thanh Khe, Da Nang, VNM

Website

http://www.danapha.com

Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.